A20 (TNFAIP3) Distinguishes Attack From Remission in Pediatric Patients With Monophasic MOGAD. - Lechner C; Saxena S; Lokhande HA; Breu M; Eisenkölbl A; Karenfort M; Klein A; Leiz S; Preisel M; Rooney T; Rosso M; Schimmel M; et al. (Neurology(R) neuroimmunology & neuroinflammation, 2025)